Table 3.
Characteristics of admitted patients with COVID-19
| Variable | COVID-19 admitted patients n = 6 |
|---|---|
| Women, n (%) | 5 (83.33) |
| Age, median (IQR), years | 14.5 (4–16) |
| Diagnosis, n (%) | |
| Systemic JIA | 1 (16.6) |
| Oligoarticular JIA with associated uveitis | 2 (28.8) |
| Systemic lupus erythematosus | 1 (16.6) |
| Vasculitis | 1 (16.6) |
| Autoinflammatory syndrome | 1 (16.6) |
| COVID-19–related treatments during admission, n (%) | |
| Hydroxychloroquine | 1 (16.6) |
| Glucocorticoids | 2 (28.8) |
| Azithromycin | 1 (16.6) |
| Lopinavir/ritonavir | 1 (16.6) |
| Admission duration, median (IQR), (days) | 5 (2–15) |
Abbreviations: IQR interquartile range, JIA Juvenile idiopathic arthritis